Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02866591
Other study ID # 2012-A00248-35
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date May 2013
Est. completion date December 2016

Study information

Verified date August 2018
Source Institut de Cancérologie de Lorraine
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Mammography is used for screening, diagnosis, therapeutic evaluation and monitoring of local cancer breast.

It is sometimes poorly tolerated by some patients who complain of an uncomfortable examination or pain.

Breast compression by the manipulator aims to reduce the thickness of the breast during mammography; This act is an important factor of pain or discomfort felt by the patient. But, it is also an image quality factor.

This study aimed to compare self-breast compression by the patient to the compression standard technique carried out by the manipulator.


Recruitment information / eligibility

Status Completed
Enrollment 550
Est. completion date December 2016
Est. primary completion date December 2016
Accepts healthy volunteers No
Gender Female
Age group 18 Years to 75 Years
Eligibility Inclusion Criteria:

- Adult patients = 18 years and = 75 years of age

- ECOG performance <2

- Mammography planned as part of a breast cancer screening or a monitoring following treatment of a breast lesion

- Ability to provide written informed consent

- Patient's legal capacity to consent to study participation and to understand and comply with the requirements of the study.

Exclusion Criteria:

- Eastern Cooperative Oncology Group performance status = 2

- Treatment for benign lesion with surgery for less than 3 years

- Treatment for cancer with surgery and / or radiotherapy for less than 3 years

- Biopsy for less than 1 year

- Breast prosthesis

- Mastectomy

- Assessment motivated by a clinical breast abnormality

Study Design


Related Conditions & MeSH terms


Intervention

Other:
mammography according to an auto-compression procedure

mammography according to a standard procedure

questionary


Locations

Country Name City State
France Institut Bergonié Bordeaux
France Centre François Baclesse Caen
France Cabinet de radiologie Nancy
France Polyclinique Majorelle Nancy
France Institut Curie Paris
France Institut de Cancérologie de Lorraine Vandoeuvre-les-Nancy

Sponsors (1)

Lead Sponsor Collaborator
Institut de Cancérologie de Lorraine

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Comparison of two breast compression techniques (auto-compression versus standard procedure) in mammography The comparison will be evaluated by the thickness (mm) of breast compressed 1 day
Secondary Overall tolerance of mammography The overall tolerance of mammography will be assessed by the patient after 4 shots. The pain felt by the patient will be assessed using a visual analog scale. 1 day
Secondary Breast compression force Value measured on compressive force console (Newtons) 1 day
Secondary Thickness / compressing force ratio 1 day
Secondary Image quality The image quality will be assessed by the radiologist with a quotation of motion blurring on a 4-point scale 1 day
Secondary Overall assessment of the manipulator The appreciation of the manipulator will be assessed using a 4-point scale 1 day
Secondary Overall assessment of self-satisfaction of the patient at the end of the examination The measurement of patient satisfaction will be evaluated using a self-administered Norwegian questionnaire (MammoGraphy Questionnaire) 1 day
See also
  Status Clinical Trial Phase
Recruiting NCT04681911 - Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer Phase 2
Terminated NCT04066790 - Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer Phase 2
Completed NCT04890327 - Web-based Family History Tool N/A
Completed NCT03591848 - Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility N/A
Recruiting NCT03954197 - Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients N/A
Terminated NCT02202746 - A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer Phase 2
Active, not recruiting NCT01472094 - The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
Completed NCT06049446 - Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
Withdrawn NCT06057636 - Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study N/A
Recruiting NCT05560334 - A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations Phase 2
Active, not recruiting NCT05501769 - ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer Phase 1
Recruiting NCT04631835 - Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer Phase 1
Completed NCT04307407 - Exercise in Breast Cancer Survivors N/A
Recruiting NCT03544762 - Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation Phase 3
Terminated NCT02482389 - Study of Preoperative Boost Radiotherapy N/A
Enrolling by invitation NCT00068003 - Harvesting Cells for Experimental Cancer Treatments
Completed NCT00226967 - Stress, Diurnal Cortisol, and Breast Cancer Survival
Recruiting NCT06019325 - Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy N/A
Recruiting NCT06037954 - A Study of Mental Health Care in People With Cancer N/A
Recruiting NCT06006390 - CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors Phase 1/Phase 2